GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Cyclically Adjusted PB Ratio

GSK (BUE:GSK) Cyclically Adjusted PB Ratio : 7.87 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2024-05-16), GSK's current share price is ARS12500.00. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ARS1,588.49. GSK's Cyclically Adjusted PB Ratio for today is 7.87.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

BUE:GSK' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.88   Med: 8.03   Max: 12
Current: 7.79

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.88. And the median was 8.03.

BUE:GSK's Cyclically Adjusted PB Ratio is ranked worse than
91.04% of 670 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs BUE:GSK: 7.79

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Mar. 2024 was ARS1,816.587. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS1,588.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.57 8.29 8.76 6.76 6.31

GSK Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.59 6.21 6.55 6.31 7.34

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.



GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12500.00/1588.49
=7.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1816.587/131.6000*131.6000
=1,816.587

Current CPI (Mar. 2024) = 131.6000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201406 10.943 99.800 14.430
201409 8.911 100.000 11.727
201412 7.331 99.900 9.657
201503 12.589 99.600 16.634
201506 12.397 100.100 16.298
201509 10.122 100.200 13.294
201512 12.717 100.400 16.669
201603 7.496 100.400 9.825
201606 1.462 101.000 1.905
201609 0.347 101.500 0.450
201612 2.832 102.200 3.647
201703 4.173 102.700 5.347
201706 2.176 103.500 2.767
201709 3.864 104.300 4.875
201712 -0.219 105.000 -0.274
201803 -0.247 105.100 -0.309
201806 15.375 105.900 19.106
201809 27.357 106.600 33.773
201812 22.719 107.100 27.916
201903 26.123 107.000 32.129
201906 25.642 107.900 31.274
201909 102.081 108.400 123.929
201912 111.917 108.500 135.744
202003 126.339 108.600 153.096
202006 145.084 108.800 175.488
202009 171.133 109.200 206.237
202012 198.255 109.400 238.486
202103 230.738 109.700 276.801
202106 253.768 111.400 299.783
202109 257.356 112.400 301.317
202112 251.129 114.700 288.131
202203 284.424 116.500 321.289
202206 298.287 120.500 325.764
202209 177.039 122.300 190.501
202212 264.291 125.300 277.579
202303 349.678 126.800 362.915
202306 469.567 129.400 477.550
202309 701.182 130.100 709.266
202312 751.810 130.500 758.147
202403 1,816.587 131.600 1,816.587

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (BUE:GSK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (BUE:GSK) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.